Company Profile

Oncolytics Biotech Inc. Stock Price, News & Analysis

Ticker:
ONCY
Exchange:
NASDAQ
Sector:
Biotechnology
Location:
Headquartered in the United States and listed on NASDAQ, Oncolytics Biotech is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.

Stock performance

0.94 USD (+2.58%)

Close

Last updated: June 23, 2026 at 00:00

112.3M USD

Market cap

Why the stock is moving

ONCY is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Business overview

Oncolytics Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, Oncolytics Biotech is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.

Business Model Characteristics

Oncolytics Biotech follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.

Position Within the Biotechnology Landscape

Compared with more mature healthcare names, Oncolytics Biotech sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.

Future catalysts

Recent news

The five most recent feed items are shown below in reverse chronological order.

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Oncolytics Biotech Inc. (ONCY)?

    Oncolytics Biotech Inc. (ONCY) most recently closed at 0.94 USD, a +2.58% move versus the previous session.

    What is the market cap of Oncolytics Biotech Inc. (ONCY)?

    Oncolytics Biotech Inc. currently has a market capitalization of 112.3M USD on BioPharmSignal.

    What does Oncolytics Biotech Inc. do?

    Oncolytics Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

    On which exchange is ONCY stock listed?

    Oncolytics Biotech Inc. (ONCY) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Oncolytics Biotech is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.

    What is Oncolytics?

    Oncolytics Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

    Which conditions is Oncolytics Biotech Inc. targeting with Oncolytics?

    Oncolytics Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

    What is Biotech?

    Oncolytics Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.